期刊文献+

黄芩苷对高脂诱发小鼠动脉粥样硬化NF-κB及ACE2蛋白表达的影响 被引量:7

The regulated effects of baicalin on NF-kB and ACE2 protein expression in atheroscherosis of ApoE-/-mice induced by hyperlipaemia
原文传递
导出
摘要 目的:观察黄芩苷对apoE-/-小鼠的主动脉壁细胞内核因子κB(NF-κB)及ACE2蛋白表达的影响,探讨黄芩苷干预动脉粥样硬化(AS)进程的可能作用机制。方法:6周龄apoE-/-小鼠30只随机分成模型组和黄芩苷高低剂量组,同时用野生型小鼠C57BL10只作为正常对照组。正常组给予普通饲料喂养,模型组和黄芩苷组给予高脂饲料喂养12周,建立小鼠AS模型,黄芩苷组给予300 mg.d-1及150 mg.d-1灌胃8周;20周后处死小鼠。实验结束后,检测血脂,免疫组化分析主动脉壁细胞内NF-κB、血管紧张素转换酶2(ACE2)表达水平。结果:黄芩苷组与模型组相比,apoE-/-小鼠主动脉壁细胞NF-κB灰度值明显升高、ACE2灰度值降低有统计学差异(P<0.05)。结论:黄芩苷可能通过抑制NF-κB转录表达,干预炎症反应进而增强ACE2蛋白表达,干预动脉粥样硬化的发生发展。 OBJECTIVE To investigate the regulated effect of baicalin on NFkB and ACE2 protein expression in atheroscle rosis (AS) of ApoE-/- mice induced by hyperlipaemia. METHODS 30 healthy six weeks aged male apoE-/- rats were random ly divided into three group as follows: model group and the high and low does baicalin group, and 10 the wild type C57BL mice were used as the normal control group, as well. Normal group was given ordinary feed, the left three groups were given high fat feed on the basis of aortic balloon technique for twelve weeks to reproduce the rat AS model, and feeding with baicalin 300 mg.d-1 and 150 mg. d-1 eight weeks. After twenty weeks of experiment, blood lipids were detected, the NF-κB and ACE2 protein expression in aortic wall cells were measured by immunohistochemical methods. RESULTS The gray value of NF-κB protein expression in baicalin group was significantly reduced, however, ACE2 grey value was increased significantly, there were significantly difference compared with the model group. CONCLUSION Baicalin may enhance the stability of the plaque, and interpose the progress of atherosclerosis by inhibiting the NF-κB expression, elevating ACE2 expression.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第1期1-4,共4页 Chinese Journal of Hospital Pharmacy
基金 山东省科技攻关计划项目(编号:2007GGB01357)
关键词 动脉粥样硬化 NF-ΚB ACE2 黄芩苷 atherosclerosis NF-κB ACE2 baicalin
  • 相关文献

参考文献15

  • 1宋立人.现代中药学大辞典[M]北京:人民卫生出版社,20012981.
  • 2Klosinska M,Rudzinski T,Grzelak P. Endothelium dependent and-independent vasodilation is more attenuated in ischaemic than in non-ischaemic heart failure[J].European Journal of Heart Failure,2009,(08):765-770.
  • 3程军,李金平,田卓,胡厚源.ApoE基因敲除小鼠和C57BL/6J小鼠血脂及主动脉组织病理学的对比观察[J].实验动物科学,2008,25(2):4-6. 被引量:8
  • 4于昕,刘向群,陈焕芹,马文健,陈效安.黄芩苷对动脉粥样硬化大鼠凝血酶激活纤溶抑制物水平及血脂、凝血纤溶指标的影响[J].中国老年学杂志,2010,30(22):3299-3301. 被引量:21
  • 5Kim DH,Kim HK,Park S. Short term feeding of baicalin inhibits age-associated NF-kappaB activation[J].Mechanisms of Ageing and Development,2006,(09):719-725.
  • 6Brand K,Page S,Rogler G. Activated transcription factor nuclear factor-kappa B is present in the atherosc]erotic lesion[J].J Clin Invcst,1996,(07):1715-1722.
  • 7Wilson SH,Caplice NM,Simari RD. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia[J].Atheroclerosis,2000,(01):23-30.doi:10.1016/S0021-9150(99)00211-7.
  • 8Chen PC,Wheeler DS,Malhotra V. A green tea-derived polyphenol,epigallocatechin-3-gallate,inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium[J].Inflammation,2002,(05):233-241.
  • 9Comalada M,Camuesco D,Sierra S. In vivo quercitrin anti inflammatory effect involves release of quercctin,which inhibits inflammation through down-regulation of the NF-kappaB pathway[J].European Journal of Immunology,2005,(02):584-592.
  • 10Chio CC,Chang YH,Hsu YW. PKA-dependent activation of PKC,p38 MAPK and IKK in macrophage:implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP[J].Cellular Signalling,2004,(05):565-575.

二级参考文献17

  • 1颜伟,胡厚源,周林,周向东,何国祥.两种LXR激动剂对ApoE基因敲除小鼠动脉粥样硬化影响的对照研究[J].第三军医大学学报,2005,27(5):381-384. 被引量:10
  • 2[1]Hump A S,Smith J D,Hayek T,et al.Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES Cells.Cell,1992.71(10):343.
  • 3[3]Breslow J B.Mouse models of athemsclemsis.SCience,1996,272:685.
  • 4[5]Nakashima Y,Plumb A S,Raines E W,et al.ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arterioscler Thromb Vasc Biol,1994,14(1):133~140.
  • 5[6]Zhang S H,Reddlck R L,Piedrahita J A.et al.Spontaneous hypercholesterolemia and arterial lesions in mice lacking aopolipoprotein E.Science,1992,258(10):468~471.
  • 6[7]Ota J,Giuliano E A,Cohn L A,et al.Local photodynamic therapy for equine squamous cell carcinoma:Evaluation of a novel treatment method in a murine model.The Veterinary Journal,Article in Press,Corrected Proof.Available online 12 Sptember 2007.
  • 7[8]Squadrito F,Minutoli L,Esposito M,et al.Lipid peroxidation triggers both c-Jun N-terminal kinase(JNK)and extracellular-regulated kinase (ERK)activation and neointimal hyperplasia induced by cessation of blood flow in the mouse carotid artery.Athermclerosis,2005,178:295~302.
  • 8Rosenfeld ME.An overview of the evolution of the atherosclerotic plaque:from fatty streak to plaque rupture and thrombosis[J].Z Kardiol,2000;89(suppl 7):2-6.
  • 9Schroeder V,Chatter T,Mehta H,et al.Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography[J].Thromb Haemost,2002;88(6):1020-5.
  • 10Silveira A,Schatteman K,Goossens F,et al.Plasma procarboxypeptidase U in men with symptomatic coronary artery disease[J].Thromb Haemost,2000;84(3):364-8.

共引文献27

同被引文献143

  • 1柴玉爽,曾瑚瑚,何源峰,尚晓,万婷,尹震,范春林,叶文才.安宫牛黄丸的UPLC特征指纹图谱与化学模式识别[J].中国中药杂志,2020,45(3):565-571. 被引量:20
  • 2陈婧,王文清,施春阳,方建国.新型冠状病毒肺炎(COVID-19)中医药防治的思考[J].中草药,2020,51(5):1106-1112. 被引量:63
  • 3康艳生,刘静静,张伟,王彤,王晓琴,梁文,艾文婷.复方丹参颗粒、复方丹参胶囊、复方丹参片与复方丹参滴丸对冠心病心绞痛患者疗效、炎性因子及氧化应激指标的影响[J].药物评价研究,2020,0(2):287-292. 被引量:48
  • 4韩学杰,张印生,沈绍功.冠心病痰瘀互结证的渊源和创新[J].中国医药学报,2004,19(10):623-625. 被引量:49
  • 5中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35:390.
  • 6Roger VL,Go AS, Lloyd Jones DM, et al. Executive summary.. Heart disease and stroke statistics- 2012 update: A report from the American Heart Association[J]. Circulation, 2012, 125 ( 1 ) : 188- 197.
  • 7Pearson TA, Mensah GA, Alexander RW, etal. Markers of in- flammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare profes- sionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003, 107(3) : 499 - 511.
  • 8Hlatky MA,Greenland P, Arnett DK, et al. Criteria for evalua- tion of novel markers of cardiovascular risk: A scientific state ment from the American Heart Association [J]. Circulation, 2009,119(17) : 2408 - 2416.
  • 9Rader D J, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis [J]. Nature, 2008,451 ( 7181 ) 904 - 913.
  • 10Wang Y, Zhang MX, Meng X, et al. Atorvastatin suppresses LPS - induced rapid upregulation of Toll- like receptor 4 and its signaling pathway in endothelial cells[J]. Am J Physiol Heart Circ Physiol,2011,300, H1743- H1752.

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部